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Abstract
Background: Obstructive Sleep Apnea (OSA) is associated with many cardiovascular and
psychiatric diseases. Day-time sleepiness is a common consequence of sleep apnea and correlates
with road-traffic accidents (RTA). Pakistan has a high prevalence of factors which predispose an
individual to OSA and death from RTAs are a huge burden. However there is a dearth of
prevalence studies in this regard. We aim to understand local relevance of the disease and estimate
the prevalence of individuals high-risk for OSA.
Methods: This cross-sectional survey was conducted among 450 individuals at Aga Khan
University Hospital (AKUH), which is a tertiary care teaching hospital in Pakistan. We used the BQ
as our measurement tool. Based on the responses, participants were grouped into high or low-risk
for OSA.
Results: Our study sample size was 418 with 63.2% males. Mean age of our study population was
30.4 SD +/- 12.3 years; and mean BMI was 23.2 SD +/- 5 kg/m2. Out of the total sample size 24.9%
reported snoring and there were twice as many males who snored as compared to females. Forty-
five individuals reported that they had nodded off to sleep while driving at least once in their
lifetime. On the other hand, the highest proportion of high risk individuals 47.6% was found in the
age group 60 or above. The overall prevalence of individuals who were high risk for sleep apnea
was 10%.
Conclusion: A significant proportion of the population is at high-risk for OSA. Our study shows
that despite low BMI and favorable craniofacial anatomy sleep apnea is still a locally relevant disease.
Given the local relevance of OSAS, it is important to increase awareness among general population
but more importantly among physicians of the developing countries, like Pakistan, about common
clinical features and pertinent risk factors and complications of OSAS.
Background
Sleep apnea is a breathing disorder characterized by snor-
ing, breathing pauses and excessive sleepiness while
awake. It is a potentially life threatening condition that is
far more common than generally understood. It is associ-
ated with a number of cardiovascular, metabolic and
neuro-cognitive complications. These complications
include hypertension [1,2], coronary artery disease [3],
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congestive heart failure [4], cerebrovascular disease [5],
atrial fibrillation[6], glucose intolerance [7], impotence
[8] and type-2 diabetes [9]. It is also related it to increased
cardiovascular mortality [10] and a high prevalence of
psychiatric co-morbid conditions such as depression, anx-
iety, posttraumatic stress disorder, psychosis, and bipolar
disorders [11]. Also it correlates with road traffic accidents
involving drivers who fall asleep while driving [12].
Published data from around the world provide informa-
tion regarding prevalence of Obstructive Sleep Apnea Syn-
drome (OSAS) the in general population. However, while
comparing data from these studies, differences among
methodologies and diagnostic criteria used, should be
noted. Many studies used questionnaires to determine
sleep apnea or its risk, where as many relied on overnight
polysomnography (PSG) studies, which is the gold stand-
ard technique for sleep apnea diagnosis. The National
Sleep Foundation poll, using the Berlin questionnaire,
found that 26% of adults of a representative sample of the
US population was at high risk for OSAS [13].
The OSAS prevalence data from Asia is scarce, however, it
is reported that prevalence ranges from 2.1 to 7.5%; with
a male-to-female ratio of 2:1 [14,15]. In India the preva-
lence of obstructive sleep apnea syndrome has been
reported to be 7.5% [16]. Despite the high prevalence of
OSAS and associated complications, majority of the
patients remain undiagnosed. For example, in US 93% of
women and 82% of men with moderate to severe OSA are
clinically undiagnosed [17]. It is perhaps not unlikely that
in less developed world, like Pakistan, an even greater pro-
portion of patients remain undiagnosed.
Systematic studies done on the Pakistani population
investigating the prevalence of OSAS are lacking. A study
done by Haqqee et al, showed a high prevalence of snor-
ing (46%); frequency of snoring with apnea was reported
to be 7% and; snoring with apnea and excessive daytime
sleepiness was 3% [18]. Haqqee et al, however did not use
a structured and/or a standardized questionnaire or an
overnight PSG. Another study recently done on seminar
participants by the authors, Taj et al [19], reports that sig-
nificant proportion of population is at risk for OSAS. Iron-
ically, most physicians in Pakistan are unaware of the
clinical features and common associations of OSAS with
18% physicians treating sleep disturbances with sedatives
only [20].
The purpose of this cross-sectional study is to perform a
survey of a Pakistani population using the standardized
Berlin questionnaire [21] and estimate the prevalence of
individuals who are at high risk for OSAS. The question-
naire uses clinical symptoms such as snoring, day time
fatigue and hypertension to classify subjects as being
either high risk or low risk for OSAS, with 86% sensitivity,
77% specificity, a positive predictive value of 0.89, and a
likelihood ratio of 3.79. There is only one study that has
so far been done in the Pakistani population to assess the
OSAS prevalence which has employed the use of the Ber-
lin Questionnaire, but it was restricted to seminar partici-
pants only [19]. We also aim to assess age, BMI and/or
gender as indicators of risk for OSAS.
Methods
Study setting and population
The study was conducted at the Aga Khan University Hos-
pital (AKUH), Karachi, Pakistan. It is a 542 beds tertiary
care hospital and one of the leading educational institutes
in the country. AKUH is the first hospital in Pakistan to be
awarded the prestigious Joint Commission International
Accreditation (JCIA) for practicing the highest interna-
tionally recognized quality standards in health care. It has
a large, broad based and busy out-patient service. The out-
patient services range from pre-employment clinics and
executive check-up clinics to specialty clinics, such as
stroke, hepatic diseases, hand-trauma etc. Patients com-
prise of all walks of life, from general population, come to
this tertiary care hospital from different parts of the coun-
try. In accordance with the cultural norms, the patient
scheduled for an appointment with the consultant physi-
cian, is usually accompanied by at least one healthy
attendant, relative or friend.
This cross-sectional survey was conducted on individuals
who had come to the hospital as attendants or visitors of
the patients. The sample was collected via convenience
sampling from out-patient clinics and community health
center of the hospital. The study was in accordance to the
Helsinki declaration and the ethics review committee at
the Aga Khan University approved it. Patient information,
including names that could link an individual to the data
was not recorded to assure confidentiality. An informed
verbal consent was obtained from each participant and
documented before the administration of the question-
naire.
Inclusion criteria
All healthy individuals, above 18 years of age, who were
accompanying a patient or were visiting a friend or rela-
tive admitted in the hospital, were included. Study objec-
tives were explained and verbal consent was obtained
prior to inclusion in the survey.
Exclusion criteria
Following individuals were excluded from the sample:
1. Any individual who was unable to read and/or under-
stand Urdu, the national language.
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2. Any individual not willing to participate in the survey.
3. Any individual who had a current illness, except hyper-
tension.
4. Any individual who had come to the hospital for med-
ical advice (consultation with a physician), or for a surgi-
cal procedure or help from associated medical staff.
5. Any individual who was currently in regular follow-up
with any physician for an illness or was taking any pre-
scription medication.
6. All persons associated with health care including doc-
tors, nursing staff and medical students.
Study Sample size
The sample population was above 18 years of age. We
required a sample size of 443 subjects to fulfill the objec-
tives of our study at a 95% confidence level. This sample
size was calculated assuming a 50% prevalence of OSAS
and 5% bound of error and then inflated by 15% to
account for non-respondents and incomplete question-
naires.
After rounding-off the required sample, we conducted the
Berlin questionnaire on a total of four hundred and fifty
individuals. Thirty-two did not answer one or more ques-
tions or terminated the interview before completion. A
total of 418 (94%) completed the interview (question-
naire) and were included in the final analysis.
Questionnaire
The instrument called the Berlin questionnaire [21], that
has been used to identify patients who are likely to have
OSAS [15], was used as the screening tool. It has been pre-
viously employed in similar primary care settings [21,22].
This instrument inquires about snoring behavior, daytime
sleepiness, obesity, and hypertension as symptoms which
help in classifying patients as being either high risk or low
risk for having sleep apnea syndrome. It has a sensitivity
of 0.86, a specificity of 0.77, a positive predictive value of
0.89, and a likelihood ratio of 3.79. It has been validated
as an authentic tool in identifying high risk patients for
Sleep Apnea syndrome in many, including US [22] and
Indian [23] populations. However it is not validated for
our Pakistani population. For our study, we translated the
questionnaire into Urdu, see additional files 1. Back-to-
back method was adopted for translation of the question-
naire.
The Berlin questionnaire begins with questions about age,
height, weight and sex. The questionnaire is then divided
into four categories. In the first category, there is one ini-
tial question about snoring, followed by four further
questions about the intensity and frequency of snoring
and witnessed episodes of apneas. In the second category
there were two questions related to day time fatigue and
tiredness, followed by two questions about sleepiness
while driving. There was only one question in the third
category regarding high blood pressure. BMI was also cal-
culated from the reported height and weight of the indi-
vidual.
Data collection
The Berlin questionnaire was administered by a group of
4th year medical students of Aga Khan University, Kara-
chi, Pakistan. Students were given ten hours of education
related to OSAS patho-physiology and its clinical features
and the questionnaire. The questionnaire was discussed
and students were trained to uniformly administer the
questionnaire and to adopt a standardized method of
interviewing.
Data entry and statistical analysis
Data was double entered and analyzed in Statistical Pack-
age for Social Sciences 14.0 (SPSS, Inc., Chicago, IL, USA)
Descriptive statistics including frequencies, means ±
standard deviations (SD) were calculated. Where appro-
priate, chi-square was used to calculate statistical signifi-
cance for qualitative variables and student t-test was used
for qualitative variables. Based on the responses of the
participants to the Berlin questionnaire they were grouped
into either high or low risk for OSAS.
In category 1, a positive score for risk was defined as an
answer in the affirmative to either of the following ques-
tion: snoring with intensity "louder than talking" or very
loud, snoring frequency > 3–4 times a week, snoring
enough to bother other people, or witnessed apneas dur-
ing sleep > 3–4 times per week.
In category 2, a positive score was defined as a patient hav-
ing a frequency of symptoms >3–4 times per week in two
or more questions about waking time sleepiness, and/or
drowsy driving.
In category 3, a positive score is given if the participant has
hypertension or has BMI greater than 27 kg/m2, the cut-
off for obesity adjusted for the Asian population accord-
ing to the latest guidelines [24,25].
Individuals were considered high risk for OSAS, if they
scored positive in two or more categories. Those who did
not have symptoms or scored positive in less than two cat-
egories were placed in the low risk group.
Results
Of the total 418 participants included in final analysis 264
(63.2%) were males and 154 (38.4%) were females. Of
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the 418 individuals, 42 were at high-risk for OSAS accord-
ing to our instrument – Berlin Questionnaire. Hence, the
prevalence estimate of individuals at high-risk for OSAS
was 10%.
Mean age was 30.4 ± 12.3 yrs (31.4 ± 13.1 years for males
and 28.6 ± 10.7 years for females). The mean BMI was
23.2 ± 5. Table 1 shows different characteristics of the
study population and their means ± S.D. along with com-
parison of mean values by gender and risk-group.
We classified 223 individuals with BMI less than 23 to be
normal (53.3%); 136 individuals with BMI between 23
and 27 kg/m2 to be over weight (32.5%) and 59 individ-
uals with BMI greater than 27 to be obese (14.1%). Only
13 individuals had BMI of more than 30 of which 8 were
classified as High Risk. Individuals whose weight or
height was not recorded were excluded prior to data anal-
ysis and constitute those 32 individuals initially excluded.
Figure 1 shows the distribution of age, BMI and other
characteristics of our study population by OSAS risk
group. Most of the participants fell in 20–29 years age
group (53.8%). It is interesting to note here that in the age
subgroup 'less than 20' years none of the respondent was
found to be high risk for OSAS. On the other hand, the
highest proportion of high risk individuals 47.6% was
found in the age group 60 or above. Our data shows that
the risk for OSAS increased with age up to 65 years of age.
Almost one-in-three participants (29%) aged 40 or more
were high-risk for OSAS.
Of the 418 respondents, 104 (24.9%) reported snoring.
Figure 1 shows the distribution of 79 males (18.9.2%)
and 25 females (6%) snorers, with snoring being more
prevalent among men as compared to women. Presence
of snoring was also found to be more prevalent in individ-
uals high-risk for OSAS (p-value < 0.0001). Of all those
who snored, including both risk groups, 49% reported
that they snored more than 3–4 times per week or more,
21.2% reported that their snoring was louder than talking
or very loud, and 42.3% admitted that their snoring both-
ered others. In the same subgroup, 24% reported wit-
nessed pauses in breathing while asleep.
Hypertension was reported by 41 individuals (7.8%). Of
these 40 (97.6%) were males. Among the high-risk group
33.3% individuals had high blood pressure as compared
to 7.2% of those in the low-risk group. Hypertension was
found to be more prevalent in the high risk group for
OSAS (p-value < 0.001).
In our study population, the prevalence of over-weight
individuals (BMI ≥ 27 kg/m2) was significantly higher
among the high-risk for OSAS group (p < 0.0001). Among
the high-risk group, 5 (11.9%) had normal BMI (< 23 kg/
m2); 12 (28.6%) were over-weight (BMI ≥ 23 -< 27 kg/m2;
and 25 (59.5%) were obese (BMI ≥ 27 kg/m2). However,
it is important to note here that 8 individuals (19%),
among high risk, had BMI greater than 30 kg/m2.
According to our data, 66 individuals (15.8%) were posi-
tive for category 1; Eighty (19.1%) individuals for cate-
gory 2; and 94 (22.5%) for category 3.
Table 2 shows the distribution of responses, on Berlin
Questionnaire, by Risk Group.
Table 1: Characteristics mean of the study population.
Characteristics Mean ± S.D. P – value
Age in years 30.38 +/- 12.3
Male 31.42 +/- 13.1
Female 28.59 +/- 10.7
Low risk group 28.8 +/- 10.9 < 0.001
High risk group 44.7 +/- 14.4
Height in meters 1.68 +/- 0.10
Male 1.73 +/- 0.09
Female 1.68 +/- 0.10
Low risk group 1.68 +/- 0.10 0.484
High risk group 1.70 +/- 0.11
Weight in Kilograms 65.3 +/- 12.6
Male 69.7 +/- 10.9
Female 57.8 +/- 11.8
Low risk group 63.5 +/- 10.9 < 0.001
High risk group 82.0 +/- 15.1
BMI in S.I units (kg/m2) 23.2 +/- 4.99
Male 23.6 +/- 4.81
Female 22.7 +/- 5.26
Low risk group 22.6 +/- 4.38 < 0.001
High risk group 28.5 +/- 6.82
Neck circumference in cm 14.1 +/- 2.81
Male 15.2 +/- 3.23
Female 12.7 +/- 1.17
Low risk group 13.9 +/- 2.88 < 0.001
High risk group 15.7 +/- 1.28
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Tiredness and sleepiness was significantly common. Out
of our total population of 418 individuals, 99 (23.7%)
reported that they felt sleepy when they woke up in the
morning greater than 3–4 times per week. One hundred
and nine (26.1%) said that they felt tired during waking
time more than 3–4 times per week. A noteworthy pro-
portion (10.8%) of our study population reported that
they had nodded off to sleep while driving at least once in
their lifetime.
Discussion and conclusion
We report the overall prevalence estimate of individuals
high-risk for OSAS to be 10%. One previous pilot study
done on a Pakistani population by the authors, Taj et al
[19], reported a much similar prevalence estimate of
12.4% among seminar attendees. Another study reports
only the prevalence of symptoms suggestive of OSA with-
out correlating them with the risk for OSA [18].
Studies from Asia measuring prevalence of OSAS are
scarce. Indian studies done using the overnight PSG
reports prevalence estimate of Sleep Disordered Breathing
(SDB) (Apnea-Hypopnea Index (AHI) ≥ 5) from 13.74%
to 19.5% [16]. The study also reports OSAHS (SDB with
daytime hyper somnolence) to be 7.5% [16]. Data from
China by Ip and colleagues [15], however, report lower
prevalence of SDB (3.7%) and OSAS (2.1%). The method-
ology employed by these two studies, done in our neigh-
boring Asian countries, is different from our Berlin
Questionnaire based study. However, there are considera-
ble inherent similarities within the classification of Sleep
Apnea syndrome. We used Berlin Questionnaire which
has 86% sensitivity for an AHI ≥ 5 and also incorporates
day-time hyper-somnolence symptoms. It is, therefore,
reasonable to compare results with these regional studies.,
Thus the point prevalence of 10% reported by our study
concurs with the regional reports.
Studies done in United States and Europe that used Berlin
questionnaire reported 26% prevalence estimate of High-
Risk for OSAS [13,22]. Our results show lower prevalence
(10%) than found in the West.
Possible reasons for this difference between prevalence of
SDB and or OSAS have been attributed to cephalometeric
differences [16]. These cephalometeric variations include
different mandibular lengths and the anteroposterior
dimensions of the nasopharynx-pharyngeal tubercle to
posterior nasal spine in the skulls from the Indian subcon-
tinent, as compared to those from other populations. This
Distribution of population age, gender, gender of snorers and BMI, according to OSAS Risk GroupFigure 1
Distribution of population age, gender, gender of snorers and BMI, according to OSAS Risk Group.
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variation also point towards the possibility of an osteo-
genic etiology of OSAS [16]. Besides distinct genetic and
environmental influences, another possible explanation
perhaps is that western populations have a higher preva-
lence of obesity and mean BMI [25].
We report 24.9% prevalence of snoring in our population,
which is similar to that reported in the Indian and Paki-
stani populations [16,19]. However, US population
reports as high as 52–54% prevalence of snoring symp-
tom [13,21]. This difference, once again, emphasizes the
differences mentioned above.
Table 2: Distribution of responses to Berlin questionnaire by risk group. (n = 418)
Questions High-Risk
n (%)
Lower-Risk
n (%)
p-value
Do you snore?
Yes 42 (100) 62 (16.5) < 0.0001
No 0 (0.00) 285 (75.8)
Don't Know 0 (0.00) 29 (7.71)
Snoring loudness
Loud as breathing 16 (38.1) 47 (72.3) < 0.0001
Loud as talking 8 (19.0) 14 (21.5)
Louder than talking 9 (21.4) 2 (3.08)
Very loud 9 (21.4) 2 (3.08)
Snoring frequency
Almost everyday 24 (57.1) 12 (18.8) < 0.0001
3–4 times/wk 9 (21.4) 6 (9.40)
1–2 times/wk 5 (11.9) 14 (21.9)
1–2 times/mo 4 (9.5) 19 (29.7)
Never or almost never 0 (0.00) 13 (20.3)
Does your snoring bother other people?
Yes 28 (66.7) 16 (24.2) < 0.0001
No 14 (33.3) 40 (60.6)
Don't Know 0 (0.00) 10 (15.2)
How often your breathing pauses have been noticed?
Almost everyday 9 (21.4) 6 (9.10) < 0.0001
3–4 times/wk 1 (2.40) 1 (1.50)
1–2 times/wk 1 (2.40) 0 (0.00)
1–2 times/mo 0 (0.00) 7 (10.6)
Never or almost never 31 (73.8) 52 (78.8)
Are you tired after sleeping?
Almost everyday 15 (35.7) 45 (12.0) < 0.0001
3–4 times/wk 4 (9.50) 35 (9.30)
1–2 times/wk 5 (11.9) 86 (22.9)
1–2 times/mo 2 (4.80) 76 (20.3)
Never or almost never 16 (38.1) 133 (35.5)
Are you tired during wake time?
Almost everyday 15 (35.7) 48 (12.9) < 0.0001
3–4 times/wk 7 (16.7) 39 (10.5)
1–2 times/wk 6 (14.3) 85 (22.8)
1–2 times/mo 4 (9.50) 90 (24.2)
Never or almost never 10 (23.8) 110 (29.6)
Have you ever fallen asleep while driving?
Yes 7 (16.7) 38 (10.3)
No 35 (83.8) 332 (89.7)
Do you have high blood pressure?
Yes 14 (33.3) 27 (7.20) < 0.0001
No 27 (64.3) 339 (90.2)
Don't know 1 (2.40) 10 (2.70)
Body Mass Index
Normal (<23 kg/m2) 5 (11.9) 218 (58.0) < 0.0001
Over weight (23 kg/m2 to less than 27.5 kg/m2) 12 (28.6) 124 (33.0)
Obese (≥ 27.5 kg/m2) 25 (59.5) 34 (9.00)
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BMI has been reported to have a linear relationship with
OSAS risk in Asian [15,16] as well as Western populations
[13]. Using the BMI cut-off, which is more sensitive for the
Asian population [24,25] we expect a similar linear rela-
tionship between OSAS and BMI in our population as
well. The difference in the prevalence of obesity, even after
using a more locally sensitive cut-off, is perhaps related to
lower estimate of OSAS prevalence in our population.
There is significant difference of mean weight and BMI
between high and low risk group (p < 0.001).
Age was also found to be an important risk factor for
OSAS as has also been found by previous surveys
[13,15,26]. In our sample population, almost one-in-
three individuals were at high-risk among those aged 40
or more. Table 1 show mean age by risk group, there is sig-
nificant difference of mean age between high and low risk
group (p < 0.001). We also report an increase in the
number of individuals at high risk for OSAS with increas-
ing age till the age of 65 years. This relates to reported
decline in OSAS risk after 65 years of age [13]. However,
the number of respondents ≥ 65 years of age in our study
was small for any significant relationship.
We also report that the snoring was significantly more
common among men compared to women.(p-value
0.001) Men were also more likely to score positive for all
3 categories of the Berlin questionnaire. This conforms to
the findings of a study performed on American and Euro-
pean subjects found that men were more likely to snore,
drive while drowsy and experience breathing pauses dur-
ing sleep [22]. Unlike previous studies [21,22], we did not
find any gender differences for OSAS risk. Perhaps, a 2:1
proportion of males-to-females in our study population
did not allow statistically significant gender differences for
OSAS risk. Interestingly, a study done on a western popu-
lation with analysis restricted to individuals with BMI less
than 30 reported no difference in the rate of OSA risk
between the two sexes [22]. Another study noted greater
gender differences for OSAS risk in higher age groups [15].
These reports support our findings as 98% of our respond-
ents have a BMI which is less than 30 and mean age of our
study population is low.
Excessive day-time sleepiness and morning fatigue corre-
late with OSAS risk and, also, excessive daytime sleepiness
is recognized as a strong indicator of OSAS [13,21]. In our
sample population, these symptoms were significantly
more prevalent among the high-risk group (p-value <
0.001). There is anecdotal evidence which suggests higher
prevalence of fatigue and sleepiness due to longer working
hours in this part of the world; hence these symptoms
may not necessarily be attributable to OSAS. It may prove
helpful to record the total sleeping hours of an individual
along with this item of the questionnaire in further stud-
ies.
Almost eleven (10.8%) percent of our total study popula-
tion reported that they had nodded off to sleep, at least
once while driving. Our reported rate is similar to that
reported in prior studies [13,21,22]. This is recognized as
an important public health hazard and in particular,
needs attention as it puts many drivers at a greater risk for
road traffic accidents [12].
Hypertension was frequently reported by our sample pop-
ulation and was significantly more common among indi-
viduals in the high risk group. OSAS is an independent
risk factor for hypertension and other cardiovascular dis-
eases [27]. Given the high prevalence of these cardiovas-
cular diseases, such as hypertension, in developing
countries like Pakistan [28], early recognition and appro-
priate management of OSAS is important. This question-
naire may be used in the office setting for screening. The
individuals identified as high-risk may be clinically con-
firmed using PSG.
Our study has certain limitations. The results are based
only on data from a single, private tertiary care hospital
that does not serve as representative of the whole popula-
tion of the country. The study was conducted in an urban
centre where risk factors associated with OSAS are
expected to be high owing to the poor socio-demographic
profile and lifestyle. Although the hospital from where the
sample was taken is visited by people from rural areas as
well, we still believe that the study setting limits the find-
ings from being representative of the whole country. We
also did not include patients who could not converse in
Urdu, and this further restricts the generalization of our
findings. Secondly, we used convenience sampling, and
so it is not possible to quantify the error in extrapolating
results to the entire population. Nevertheless, the use of
the structured and validated Berlin questionnaire in our
study strengthens the reliability of our results. It may be
noted that the Berlin questionnaire is not particularly val-
idated for Pakistani population. Also, a two-to-one ratio
of male-to-female in our population probably overesti-
mated the OSA-risk prevalence. The height and weight
were self reported and subsequent discrepancies in the
BMI had to be disregarded. We did not exclude partici-
pants with specific medical conditions, such as hypothy-
roidism, asthma, acromegaly, heart disease, renal disease,
pregnancy, hormonal replacement therapy etc., which
may further limit the strength of our analysis.
In conclusion, efforts are needed at the national and
regional level and, perhaps, in other developing countries
to address this problem. Considering the serious adverse
health and quality-of-life consequences of OSAS, it is
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important to completely decipher its epidemiology. Fur-
ther assessment of the prevalence of OSAS by overnight
PSG along with appropriate screening tools will be mean-
ingful. Apart from more accurate estimates, it will help
evaluate the aptness and validate the screening method
e.g. the Berlin questionnaire for the local population.
Given the local relevance of OSAS, it is important to
increase awareness among not only the general popula-
tion but more importantly among the physicians of devel-
oping countries, like Pakistan, about the common clinical
features, pertinent risk factors and complications of OSAS.
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